AVAH Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
670.5M
+3.5%
647.9M
-2.2%
662.5M
+6.5%
621.9M
+5.5%
589.6M
Cost of Revenue
452.0M
+2.1%
442.5M
-1.5%
449.2M
+7.2%
419.1M
+10.7%
378.8M
Gross Profit
218.5M
+6.4%
205.4M
-3.7%
213.3M
+5.2%
202.8M
-3.8%
210.8M
Operating Expenses
138.5M
+1.8%
136.1M
-4.3%
142.3M
-4.7%
149.2M
+14.1%
130.8M
R&D
0
0
0
0
0
SG&A
97.1M
+1.3%
95.8M
+462.9%
-26393000
-117.9%
147.4M
+63.7%
90.1M
Operating Income
80.0M
+15.4%
69.3M
-2.4%
71.0M
+32.6%
53.6M
-33.0%
80.0M
EBITDA
87.2M
+15.6%
75.5M
+0.3%
75.3M
+36.8%
55.0M
-36.1%
86.1M
Net Income
40.3M
-3.3%
41.7M
-76.7%
178.8M
+1171.0%
14.1M
-48.0%
27.0M
EPS (Basic)
$0.19
+0.0%
$0.19
-77.6%
$0.85
+1114.3%
$0.07
-46.2%
$0.13
EPS (Diluted)
$0.18
-5.3%
$0.19
-76.5%
$0.81
+1250.0%
$0.06
-53.8%
$0.13
Shares (Diluted)
224.9M
+1.2%
222.1M
+0.5%
221.0M
-0.6%
222.2M
+5.6%
210.4M
Aveanna Healthcare (AVAH) โ€” Financials